By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Topical antifungals > Ting af > Miconazole Topical Dosage
Topical antifungals
https://themeditary.com/dosage-information/miconazole-topical-dosage-10572.html

Miconazole Topical Dosage

Drug Detail:Ting af (Miconazole topical [ my-con-a-zole ])

Drug Class: Topical antifungals Vaginal anti-infectives

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Vaginal Candidiasis

Vaginal suppository:
1 day therapy: Insert 1200 mg suppository intravaginally at bedtime for 1 day.
3 day therapy: Insert 200 mg suppository intravaginally at bedtime for 3 days.
7 day therapy: Insert 100 mg suppository intravaginally at bedtime for 7 days.

Vaginal cream:
Intravaginally:
2% cream: Insert one applicatorful intravaginally at bedtime for 3 to 7 days.
4% cream: Insert one applicatorful intravaginally at bedtime for 3 days.

Topically: Apply to external vulvar area twice a day for up to 7 days, as needed.

Usual Adult Dose for Tinea Corporis

Topical cream, ointment, powder, spray, or tincture: Apply a thin layer to affected areas twice a day for 4 weeks.

Usual Adult Dose for Tinea Pedis

Topical cream, ointment, powder, spray, or tincture: Apply a thin layer to affected areas twice a day for 4 weeks.

Usual Adult Dose for Cutaneous Candidiasis

Topical cream, ointment, powder, or spray: Apply a thin layer to affected areas twice a day for 2 weeks.

Usual Adult Dose for Tinea Cruris

Topical cream, ointment, powder, or spray: Apply a thin layer to affected areas twice a day for 2 weeks.

Usual Adult Dose for Tinea Versicolor

Topical cream: Apply a thin layer to affected areas once a day.
Clinical and mycological clearing usually occur after 2 weeks of therapy.

Usual Pediatric Dose for Vaginal Candidiasis

12 years or older:
Vaginal suppository:
1 day therapy: Insert 1200 mg suppository intravaginally at bedtime for 1 day.
3 day therapy: Insert 200 mg suppository intravaginally at bedtime for 3 days.
7 day therapy: Insert 100 mg suppository intravaginally at bedtime for 7 days.

Vaginal cream:
Intravaginally:
2% cream: Insert one applicatorful intravaginally at bedtime for 3 to 7 days.
4% cream: Insert one applicatorful intravaginally at bedtime for 3 days.

Topically: Apply to external vulvar area twice a day for up to 7 days, as needed.

Usual Pediatric Dose for Tinea Corporis

2 years or older:
Topical cream, ointment, powder, spray, or tincture: Apply a thin layer to affected areas twice a day for 4 weeks.

Usual Pediatric Dose for Tinea Pedis

2 years or older:
Topical cream, ointment, powder, spray, or tincture: Apply a thin layer to affected areas twice a day for 4 weeks.

Usual Pediatric Dose for Cutaneous Candidiasis

2 years or older:
Topical cream, ointment, powder, or spray: Apply a thin layer to affected areas twice a day for 2 weeks.

Usual Pediatric Dose for Tinea Cruris

2 years or older:
Topical cream, ointment, powder, or spray: Apply a thin layer to affected areas twice a day for 2 weeks.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Patients should be advised to notify their physician if symptoms have not improved after completion of the treatment period and to discontinue use if increased signs of irritation or sensitivity (e.g., redness, itching, burning, blistering, swelling, oozing) develop.

Patients should be reevaluated and the diagnosis reconsidered if no improvement is noted after completion of the treatment period.

Patients should not use miconazole vaginal cream or suppositories if they have abdominal pain, fever, or offensive-smelling vaginal discharge.

Safety and effectiveness of the topical cream, topical ointment, topical powder, topical spray, and topical tincture have not been established in pediatric patients less than 2 years of age. Safety and effectiveness of the vaginal cream and vaginal suppository have not been established in pediatric patients less than 12 years of age.

Dialysis

Data not available

Other Comments

A physician should be consulted before initiating treatment of a vaginal condition. Some vaginal conditions have symptoms similar to a yeast infection, such as sexually transmitted disease (STD) or a tubal pregnancy.

In patients with frequent recurrent candidal vaginitis, it is important to consider factors that predispose to infection (other drugs and/or the use tight-fitting garments).

Patients should avoid sexual intercourse during use of intravaginal miconazole suppositories.

Frequently asked questions

  • Why does Monistat burn/itch so bad?
  • Monistat-1: white discharge and burning, is this normal?
  • Do you wash Monistat out in the morning?
  • How long do you have to lay down for after using Monistat?
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by